Company: G
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001398659-25-000109
Chunk: 39

Company: Genpact LTD
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 39
---
$145,831 $371,755 $409,400 Earnings per common share17Basic$0.75 $0.84 $2.07 $2.35 Diluted$0.74 $0.83 $2.06 $2.31 Weighted average number of common shares used in computing earnings per common share17Basic177,595,400 173,576,957 179,221,213 174,572,169 Diluted179,714,223 176,104,577 180,854,682 177,197,356     

See accompanying notes to the Consolidated Financial Statements.    

4

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

(In thousands)

 Three months ended September 30,Nine months ended September 30,2024202520242025Net income$132,818 $145,831 $371,755 $409,400 Other comprehensive income:Currency translation adjustments22,765 (50,757)(1,695)(746)Gain (loss) on cash flow hedging derivatives, net of taxes (Note 6)(18,583)(44,140)(11,810)(27,756)Retirement benefits (expense), net of taxes(185)(110)(439)114 Other comprehensive income (loss) 3,997 (95,007)(13,944)(28,388)Comprehensive income$136,815 $50,824 $357,811 $381,012 

See accompanying notes to the Consolidated Financial Statements.

5

 GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity 

For the three months ended September 30, 2024

(Unaudited)

(In thousands, except share count)

 Common sharesAccumulated OtherComprehensiveIncome (Loss)No. ofSharesAmountAdditional Paid-in CapitalRetainedEarningsTotalEquityBalance as of July 1, 2024178,177,581 $1,776 $1,900,015 $1,176,459 $(740,491)$2,337,759 Issuance of common shares on exercise of options (Note 15)Issuance of common shares under the employee stock purchase plan (Note 15)69,393 1